Successful Project Management for Implementing Single-Use Bioprocessing Systems - - BioPharm International

ADVERTISEMENT

Successful Project Management for Implementing Single-Use Bioprocessing Systems


BioPharm International


In its early days, the biotech industry was almost entirely science driven, but it has since expanded from a laboratory environment to a sophisticated and dynamic manufacturing environment. As technological discoveries are increasingly translated into commercial products, biotech companies are realizing that they must generate a stronger return on assets.

The implications of this evolution are that production costs and capacity utilization are becoming critical success factors. In general terms, the drive for operational excellence requires initiatives that improve quality, increase throughput, and reduce waste. This translates into

  • Improving asset utilization
  • Improving quality by reducing deviations and sterility failures
  • Improving yield and recoveries

Biotech facilities are complex and highly regulated, and the industry is on the lookout for technologies that can simplify operations, improve product security, speed up changeovers and consequently improve quality and reduce costs. For this reason, we have seen rapid adoption of single-use technologies, particularly over the last five years. Single-use technologies can play a significant role in this drive for operational excellence by offering closed, sterile, ready-to-use systems that eliminate the risk of cross contamination and the need for cleaning and cleaning validation. This enables faster turnaround and hence higher throughput.


The range of single-use products available
Single-use system manufacturers have been actively expanding their range of product offerings (see sidebar). As the list of components available in disposable format increases, the vision of a single-use process train comes closer to reality. But how simple is this technology to implement and operate? How easy is it to validate? How does it compare to the well established conventional technology that the industry has been using for years? This is what this article sets out to examine.

Project management for implementing disposables

The design and specification of process equipment and support operations typically are determined early in facility design, because these factors have a direct impact on facility architecture, utilities, air classifications, and flows of process, material, and personnel. So how do industry end-users evaluate the implementation of single-use systems for a new facility or retrofit project? Two managers with recent experience in this area give their views.

Perspective 1: Using Disposables in a New Facility

Karin Wassard, production director for Bavarian Nordic's smallpox vaccine manufacturing facility, evaluated the use of disposables for a new site.


Figure 1. Arrival of growth media at a manufacturing site docked straight through the wall, using an aseptic transfer port.
This plant was to be used to manufacture vaccines using the MVA-BN virus, which is the largest known DNA virus and is too big to be sterile filtered. "Therefore, we needed aseptic production from A to Z—either using a completely closed process or by having all open processes in a class 100 environment," says Wassard. "We chose to create both class 10,000 and class 100 areas, and to ensure an aseptic process we also aimed to minimize the number of open manipulations." The final setup is an almost completely closed process; this design was facilitated, among other things, by extensive use of sterile single-use bags, tubes, connectors, and aseptic zone-to-zone transfer technology (Figure 1).

Despite designing the process around closed systems wherever possible, Wassard decided to go for a low risk approach in construction by keeping room classifications high. This was decided due to parallel activities in closing the process and construction on site.

Bavarian Nordic worked with separate partners who handled engineering, process scale-up and optimization, and disposable systems. The final process design for the disposables implementation was carried out by Bavarian Nordic in collaboration with disposable system providers.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here